Entrada Therapeutics, Inc.
$4.37
-0.41 (-8.58%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -36.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -43.8%
Own TRDA?
See how TRDA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.